<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-07-02T22:27:31.6138523+02:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-07-02T00:00:00+02:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-COD-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investment for impact against Tuberculosis and HIV in the Democratic Republic of the Congo - Congo (Democratic Republic) (01-Oct-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Congo (Democratic Republic), TB/HIV, United Nations Development Programme (UNDP/RBA)This program has the following goals: Contribuer à l'accéleration du progres vers la fin de l'épidemie de la TB en RDC / Contribute to accelerating progress towards the end of the TB epidemic in DRC.  Faire de la RDC un pays avec « ZERO nouvelle infection, ZERO décès lié au VIH/Sida et ZERO discrimination et stigmatisation » dans la perspective qu’en RDC, le VIH ne soit plus un problème de santé Publique à l’horizon 2030. / To make the DRC a country with  ZERO new infections, ZERO HIV/AIDS-related deaths, and ZERO discrimination and stigmatization  so that by 2030, HIV will no longer be a public health problem in the DRC.. The objectives of this program are: Dépister  un total cumulé de 854 736  cas  de TB toutes formes dans le cadre du GC7 parmi lequel 137 901 enfants et 6330  cas de TBMR / Screen a cumulative total of 854,736 cases of all forms of TB within the framework of GC7, including 137,901 children and 6,330 cases of MDR-TB.  Traiter avec succès au moins 95% des patients TB PS notifiés et au moins 85 % des TB MR notifiés; / Successfully treat at least 95% of notified SP-TB patients and at least 85% of notified MDR-TB patients;.  Mettre sous traitement d’infection latente  enfants de moins de 5 ans en contact avec des cas TB+  exclue de la TB (352 801) ; / Put on treatment for latent infection children under 5 years of age in contact with TB+ cases excluded from TB (352,801);.  Tester au VIH au moins 90% des patients tuberculeux notifiés  durant la période  ; / Test at least 90% of TB patients notified during the period for HIV;.  Mettre sous ARV 95% des patients coïnfectés (TB VIH+) durant la période dans le pays ; / Put 95% of co-infected patients (HIV+ TB) on ARVs during the period in the country;.  Réduire les nouvelles infections VIH de 95% d’ici  2027 / Reduce new HIV infections by 95% by 2027.  Réduire les nouvelles infections chez les nourrissons nés des mères infectées par le VIH de 98 % d'ici 2027 / Reduce new infections among infants born to HIV-infected mothers by 98% by 2027.  Réduire la mortalité liée au VIH de 9.5% à 7.4% / Reduce HIV-related mortality from 9.5% to 7.4% by the end of 2027.  Reduire la discrimination, la stigmatisation et les inégalités sociales liées au VIH/TB à l’égard des  PVVIH, populations clés (Transgenre, HSH, PS, UDI, PS, détenus ) et autres populations vulnérables (SVS, SVBG et OEV) de 95%  d’ici fin  2027 / Reduce discrimination, stigma and social inequalities related to HIV/TB for PLHIV, key populations (Transgender, MSM, PS, IDU, PS, prisoners) and other vulnerable populations (SVS, SVBG and OVC) by 95% by the end of 2027.  Soutenir la riposte nationale VIH par une bonne gouvernance et une coordination multisectorielle optimale à tous les niveaux d’ici à 2027 / Support the national HIV response through good governance and optimal multisectoral coordination at all levels by 2027</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="COD-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-10-01" />
		<activity-date type="2" iso-date="2024-10-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="CD" percentage="100">
			<narrative xml:lang="en">Congo (Democratic Republic)</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="45">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="21">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="3">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="31">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for AGYW and their male sexual partners programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing outside of KP and AGYW programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Condom and lubricant programming for prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Overdose prevention and management for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="22">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="21">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Biosafety and biosecurity, infrastructure and equipment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="19">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-10-01">73807884.44</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2026-01-01" />
			<period-end iso-date="2026-12-31" />
			<value currency="USD" value-date="2024-10-01">64664619.95</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-10-01">1571338.51</value>
		</budget>
		<transaction ref="44b19a24-36aa-4a9f-a897-d82ee08a5e40">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-12-01" />
			<value currency="USD" value-date="2025-12-01">21191461.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b48b99d5-26f8-4930-a3be-51b4eb26c1cd">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-11-04" />
			<value currency="USD" value-date="2025-11-04">-36292702.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bc0583ea-1cd6-4d0c-8d2a-769fa2a50192">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-11-04" />
			<value currency="USD" value-date="2025-11-04">0.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1b9b2765-ce61-4145-893b-a156ef227a16">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-11-08" />
			<value currency="USD" value-date="2024-11-08">101894342.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="73dbf718-70d5-476b-b05c-680b5c6064f7">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-10-04" />
			<value currency="USD" value-date="2024-10-04">42828746.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bbe62d51-2d23-40d7-846f-979d7d1cb405">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-11-12" />
			<value currency="USD" value-date="2024-11-12">5951605.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0762e190-94ee-4669-9712-390d60ad487f">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-12-09" />
			<value currency="USD" value-date="2025-12-09">3183497.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a2923390-52e9-4f57-997e-45d5211071af">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-04-28" />
			<value currency="USD" value-date="2025-04-28">59650035.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2d52c285-26e9-44a9-967d-896262961d41">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-03-17" />
			<value currency="USD" value-date="2026-03-17">14717018.57</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1efc5fc4-f40d-422b-826f-cc8e7751fb8a">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-10-08" />
			<value currency="USD" value-date="2024-10-08">42828746.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to COD-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/COD-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-07-02" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-07-02" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for COD-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="82.97" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="HIV status" value="Positive" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Provider type" value="Public" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="1836">
						<dimension name="Treatment regimen" value="Shorter 6-9 month" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="HIV status" value="Unknown" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="HIV status" value="Negative" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="84.59" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Age" value="&lt;15" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Age" value="15+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="79.08">
						<dimension name="Age" value="15+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="29.82">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Treatment regimen" value="Longer individualized" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="53.14">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Provider type" value="Private" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="3.89">
						<dimension name="Age" value="&lt;15" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="0">
						<dimension name="Provider type" value="Public" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="87.47" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="82.97" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="3.79">
						<dimension name="Age" value="&lt;15" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="31.82">
						<dimension name="Age" value="&lt;15" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="33.71">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="87.66" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="80.18" />
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="89.38" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Treatment regimen" value="Longer individualized" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="66.29">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="57.68">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="96.21">
						<dimension name="Age" value="15+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="42.32">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="80.18" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="5">
						<dimension name="Treatment regimen" value="Longer individualized" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="1237">
						<dimension name="Treatment regimen" value="Shorter 6-9 month" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="444">
						<dimension name="Treatment regimen" value="Shorter 6-9 month" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="89.32">
						<dimension name="Age" value="15+" />
					</actual>
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HPM 6 other-3 Percentage of healthcare establishments with HIV diagnostic tests available on the day of the visit or the day the report was drawn up</narrative>
				</title>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="34.14" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="34.14" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="58.96" />
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="58.96" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs</narrative>
				</title>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="8.25" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="8.25" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="1144">
						<dimension name="Age" value="15-19" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="6266">
						<dimension name="Age" value="25+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="973">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="8431">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="1.35" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="0">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="1.35" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="1994">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HPM 4 other-1 Percentage of healthcare organisations with tuberculosis marker drugs on the day of the visit or on the day the report is drawn up</narrative>
				</title>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="69.52" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="69.52" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="54.60" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="54.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="30248">
						<dimension name="Age" value="25+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="56273">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="17.25" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="9346">
						<dimension name="Age" value="15-19" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.03" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.03" />
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="17.25" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="16679">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Transgender" />
					</actual>
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs</narrative>
				</title>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="4344">
						<dimension name="Age" value="15-19" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="22.11" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="22.11" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.45" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="15032">
						<dimension name="Age" value="25+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.45" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="9014">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs</narrative>
				</title>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Transgender" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="34957">
						<dimension name="Age" value="25+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="66065">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="20.25" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="19174">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="11934">
						<dimension name="Age" value="15-19" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.13" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.13" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="20.25" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="0">
						<dimension name="Gender" value="Transgender" />
					</actual>
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="11499">
						<dimension name="Gender" value="Male" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="11.25" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="1.32" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="1.32" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="3641">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="1327">
						<dimension name="Gender" value="Female" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="11.25" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="7324">
						<dimension name="Age" value="25+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="1861">
						<dimension name="Age" value="15-19" />
					</actual>
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HPM 5 other-2 Percentage of healthcare organisations with HIV marker drugs on the day of the visit or on the day the report is drawn up</narrative>
				</title>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="88.08" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="88.08" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="45.73" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="45.73" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
				</title>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="30.93" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="23.71" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="23.71" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="37.35" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of individual HIV self-test kits distributed</narrative>
				</title>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="3297">
						<dimension name="Age" value="15-19" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="19089">
						<dimension name="Age" value="25+" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="7406">
						<dimension name="Age" value="20-24" />
					</actual>
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="23.20" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
					<actual value="23.20" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
					<actual value="2.31" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of MSM who received any PrEP product at least once during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-01-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2024-10-01" />
					<period-end iso-date="2024-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
				<period>
					<period-start iso-date="2025-07-01" />
					<period-end iso-date="2025-12-31" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>